Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 5:37 pm Purchase | 13G | CENTESSA PHARMACEUTICALS PLC S CNTA | EcoR1 Capital LLC | 5,618,779 5.8% | 386,500 (+7.39%) | View |
| 2024-02-14 10:13 am Purchase | 13G | CENTESSA PHARMACEUTICALS PLC S CNTA | BIOTECHNOLOGY VALUE FUND L P | 8,774,570 9% | 1,880,225 (+27.27%) | View |
| 2023-02-09 10:35 am Sale | 13G | CENTESSA PHARMACEUTICALS PLC S CNTA | JANUS HENDERSON GROUP PLC JHG | 2,114,519 2.2% | -3,628,878 (-63.18%) | View |
| 2023-01-31 4:00 pm Purchase | 13G | CENTESSA PHARMACEUTICALS PLC S CNTA | Medicxi Growth I LP | 19,963,157 21.1% | 1,839,265 (+10.15%) | View |
| 2022-11-23 12:28 pm Purchase | 13G | CENTESSA PHARMACEUTICALS PLC S CNTA | EcoR1 Capital LLC | 5,232,279 5.5% | 5,232,279 (New Position) | View |
| 2022-06-16 5:24 pm Purchase | 13G | CENTESSA PHARMACEUTICALS PLC S CNTA | BIOTECHNOLOGY VALUE FUND L P | 6,894,345 7.3% | 6,894,345 (New Position) | View |
| 2022-02-14 08:07 am Purchase | 13G | CENTESSA PHARMACEUTICALS PLC S CNTA | INDEX VENTURES LIFE VI (JERSEY) L.P. | 9,961,789 11.1% | 9,961,789 (New Position) | View |
| 2022-02-11 1:47 pm Purchase | 13G | CENTESSA PHARMACEUTICALS PLC S CNTA | JANUS HENDERSON GROUP PLC JHG | 5,743,397 6.4% | 5,743,397 (New Position) | View |
| 2022-02-08 08:27 am Purchase | 13G | CENTESSA PHARMACEUTICALS PLC S CNTA | Medicxi Growth I LP | 18,123,892 20.16% | 18,123,892 (New Position) | View |
| 2021-06-11 4:59 pm Purchase | 13D | CENTESSA PHARMACEUTICALS PLC S CNTA | General Atlantic Cooperatief U.A. | 9,681,818 10.8% | 9,681,818 (New Position) | View |